Ad
ACRX - AcelRx Pharmaceuticals Stock Trading
About | AcelRx Pharmaceuticals Inc. (NASDAQ:ACRX)
Not available
Quote | AcelRx Pharmaceuticals Inc. (NASDAQ:ACRX)
| Last: | $0.58 |
|---|---|
| Change Percent: | -0.17% |
| Open: | $0.59 |
| Close: | $0.58 |
| High: | $0.609 |
| Low: | $0.58 |
| Volume: | 342,527 |
| Last Trade Date Time: | 09/29/2023 03:00:00 am |
News | AcelRx Pharmaceuticals Inc. (NASDAQ:ACRX)
-
2023-09-12 11:00:56 ET More on AcelRx Pharmaceuticals Seeking Alpha’s Quant Rating on AcelRx Pharmaceuticals Historical earnings data for AcelRx Pharmaceuticals Financial information for AcelRx Pharmaceuticals AcelRx upgraded at HC Wainwright on likely...
-
2023-08-18 18:33:45 ET More on AcelRx Pharmaceuticals AcelRx Pharmaceuticals launches ~$10M private placement of shares AcelRx adds 16% on plans to divest pain therapy AcelRx announces $7.5M direct offering of common stock and warrants AcelRx Pharma rises 8% ...
Message Board Posts | AcelRx Pharmaceuticals Inc. (NASDAQ:ACRX)
| Subject | By | Source | When |
|---|---|---|---|
| $ACRX AcelRX Pharmaceuticals Inc | mick | investorshub | 04/30/2023 10:12:48 PM |
| $ACRX AcelRX Pharmaceuticals Inc | mick | investorshub | 04/15/2023 6:04:32 PM |
| Well , THAT report was ugly .. | molee | investorshub | 03/31/2023 5:34:04 PM |
| Loading up .70 for events,30th ,I dont want | 81vette | investorshub | 03/28/2023 5:58:52 PM |
| Loading up .70 for events,30th ,I dont want | 81vette | investorshub | 03/28/2023 5:58:50 PM |
AcelRx Pharmaceuticals Inc. Company Name:
ACRX Stock Symbol:
NASDAQ Market:
AcelRx Pharmaceuticals Inc. Website:
Ad
-
Gainers ShiftPixy, Inc. (NASDAQ: PIXY) shares rose 69.9% to $0.7391 in pre-market trading. The company announced the effective date for its revers...
-
Goldman Sachs increased the price target for Constellation Brands, Inc. (NYSE: STZ) from $275 to $305. Goldman Sachs analyst Bonnie Herzog maint...
-
AcelRx Reports Second Quarter 2023 Financial Results and Provides Corporate Update PR Newswire Capital raise closed in July, led by new healthcare investors; provides access to up to $26.3 million in capital, with $10 million immediately available AcelRx awaits...